(4-Methylpiperazin-1-yl)piperidin-4-yl-methanone dihydrochloride

Catalog No. :
ACZNKP048
CAS No. :
1019852-03-9
Molecular Formula :
C11H23Cl2N3O
Molecular Weight :
284.23

IUPAC Name:(4-methylpiperazin-1-yl)(piperidin-4-yl)methanone dihydrochloride

(4-Methylpiperazin-1-yl)piperidin-4-yl-methanone dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$117.00Login to see priceInquiryInquiry
5g95%$369.00Login to see priceInquiryInquiry
10g95%$640.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-Methylpiperazin-1-yl)piperidin-4-yl-methanone dihydrochloride
IUPAC Name(4-methylpiperazin-1-yl)(piperidin-4-yl)methanone dihydrochloride
Molecular FormulaC11H23Cl2N3O
Molecular Weight284.23
SMILESCl.Cl.CN1CCN(CC1)C(=O)C2CCNCC2
InChI KeyJYYMLZLAIOASOM-UHFFFAOYSA-N
Synonym(4-methylpiperazin-1-yl)piperidin-4-yl-methanone dihydrochloride | 63214-56-2 | 1019852-03-9 | 1-methyl-4-(piperidine-4-carbonyl)piperazine dihydrochloride | (4-methylpiperazin-1-yl)(piperidin-4-yl)methanone dihydrochloride | MFCD05864745 | (4-methyl-piperazin-1-yl)-
CAS No.1019852-03-9
PubChem CID45036889

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACZNKP048 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZNKP048 route product structure diagram
    ACZNKP0481019852-03-9
Inquiry

2. ACZNKP048 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACZNKP048 route product structure diagram
    ACZNKP0481019852-03-9
Inquiry

Comments (0)